Literature DB >> 8274447

Cyclin gene expression and growth control in normal and neoplastic human breast epithelium.

R L Sutherland1, C K Watts, E A Musgrove.   

Abstract

Recent advances in defining the molecular mechanisms of cell cycle control in eukaryotes provide a basis for better understanding the hormonal control of cell proliferation in normal and neoplastic breast epithelium. It is now clear that a number of critical steps in cell cycle progression are controlled by families of serine/threonine kinases, the cdks. These kinases are activated by interactions with various cyclin gene products which form the regulatory subunits of the kinase complexes. Several families of cyclins control cell cycle progression in G1 phase, cyclins C, D and E, or in S, G2 and mitosis, cyclins A and B. Recent studies have defined the expression and regulation of cyclin genes in normal breast epithelial cells and in breast cancer cell lines. Following growth arrest of T-47D breast cancer cells by serum deprivation restimulation with insulin results in sequential induction of cyclin genes. Cyclin D1 mRNA increases within 1 h of mitogenic stimulation and is followed by increased expression of cyclins D3 and E in G1 phase, cyclin A in late G1/early S phase and cyclin B1 in G2. Similar results were observed following epidermal growth factor stimulation of normal breast epithelial cells. Other hormones--oestrogens and progestins--and growth factors--insulin-like growth factor-I and basic fibroblast growth factor--with actions in G1 were also investigated for their effects on G1 cyclin gene expression. In all cases there was an excellent correlation between the induction of cyclin D1 mRNA and subsequent entry into S phase. Furthermore, growth inhibition by antioestrogens and concurrent G1 arrest were preceded by an acute decrease in cyclin D1 gene expression. These observations suggest a likely role for cyclin D1 in mediating many of the known hormonal effects on cell proliferation in breast epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274447     DOI: 10.1016/0960-0760(93)90062-2

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  6 in total

Review 1.  Cell cycle regulators and their abnormalities in breast cancer.

Authors:  P L Fernández; P Jares; M J Rey; E Campo; A Cardesa
Journal:  Mol Pathol       Date:  1998-12

2.  Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor).

Authors:  R Lu; G Serrero
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

3.  Silencing of Her2, CCNB1 and PKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division.

Authors:  I A Akimov; E L Chernolovskaya; Yu E Spitsyna; E I Ryabchikova; M A Zenkova
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

4.  Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.

Authors:  Min Wei; Qi He; Zhongyin Yang; Zhiwei Wang; Qing Zhang; Bingya Liu; Qinlong Gu; Liping Su; Yingyan Yu; Zhenggang Zhu; Guofeng Zhang
Journal:  BMC Cancer       Date:  2014-01-08       Impact factor: 4.430

5.  P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.

Authors:  Tonghui Li; Fangfang Wang; Yanmei Dang; Jiajie Dong; Yu Zhang; Chi Zhang; Ping Liu; Yanhong Gao; Xiaojun Wang; Sijun Yang; Shan Lu
Journal:  Int J Biol Sci       Date:  2019-08-19       Impact factor: 6.580

6.  Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status.

Authors:  N H Nielsen; C Arnerlöv; S O Emdin; G Landberg
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.